These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 535188)

  • 1. Macrophage-alloantibody-target cell interactions. III. Stripping of antibody-coated cells by human macrophages.
    Halloran PF; Stubbs M
    Clin Exp Immunol; 1979 Dec; 38(3):568-77. PubMed ID: 535188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-alloantibody-target cell interactions. II. Nonphagocytic effects.
    Halloran PF; Stylianos SK
    Transplantation; 1979 Mar; 27(3):180-5. PubMed ID: 432938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloantibody-induced cytotoxicity of macrophages.
    Ptak W; Hanczakowska M
    J Immunol; 1975 Sep; 115(3):796-9. PubMed ID: 1151077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage dependent protection of tumour cells.
    Hersey P; MacLennan IC
    Immunology; 1973 Feb; 24(2):385-93. PubMed ID: 4714057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for several cell populations active in antibody dependent cellular cytotoxicity.
    Zighelboim J; Bonavida B; Fahey JL
    J Immunol; 1973 Dec; 111(6):1737-42. PubMed ID: 4750865
    [No Abstract]   [Full Text] [Related]  

  • 6. Augmentation of antibody-dependent cell-mediated cytotoxicity by anti-immunoglobulin. I. Relationship to target cell capping.
    Halloran PF; Stylianos SK
    Clin Exp Immunol; 1980 Oct; 42(1):127-35. PubMed ID: 6970095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human monoclonal antibodies to B lymphocyte cell surface antigens: a study of the primary alloantibody response.
    Power DA; d'Apice AJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):119-20. PubMed ID: 2784886
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibodies which react with lymphocyte-lysed target cells and which cross-react with complement-lysed ghosts.
    Ward RH; Lachmann PJ
    Immunology; 1985 Sep; 56(1):179-88. PubMed ID: 4043993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of murine lung and peritoneal macrophages.
    Hearst JE; Warr GA; Jakab GJ
    J Reticuloendothel Soc; 1980 May; 27(5):443-54. PubMed ID: 7373609
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts.
    Shin HS; Hayden M; Langley S; Kaliss N; Smith MR
    J Immunol; 1975 Apr; 114(4):1255-63. PubMed ID: 1078832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage-alloantibody-target cell interactions. I. Assessment of macrophage effector function.
    Halloran PF; Stylianos SK
    Transplantation; 1978 Jun; 25(6):296-301. PubMed ID: 664007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rosette formation by peritoneal cells of non-immunized mice].
    Bendinelli M; Saracchi L
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1970; 63(1):27-38. PubMed ID: 5506658
    [No Abstract]   [Full Text] [Related]  

  • 13. Ex vivo-activated human macrophages kill chronic lymphocytic leukemia cells in the presence of rituximab: mechanism of antibody-dependent cellular cytotoxicity and impact of human serum.
    Lefebvre ML; Krause SW; Salcedo M; Nardin A
    J Immunother; 2006; 29(4):388-97. PubMed ID: 16799334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human alloantiserum against PHA-activated cells. Cytotoxicity associated with the HLA-A3 antigen.
    Bućin D; Löw B
    Tissue Antigens; 1985 Jan; 25(1):50-4. PubMed ID: 3872487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific surface antigens expressed on activated mouse peritoneal macrophages and recognized by a novel monoclonal antibody.
    Someya A
    Immunology; 1985 Dec; 56(4):683-8. PubMed ID: 3908293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune mechanisms against canine distemper. III. Role of complement lysis in the immunity and persistent infection of canine distemper virus.
    Ho CK; Babiuk LA
    Immunology; 1980 Feb; 39(2):231-7. PubMed ID: 7380468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct tumor cell and antibody-dependent cell-mediated cytotoxicity by macrophages form germfree and conventional rats.
    Johnson WJ; Balish E
    J Reticuloendothel Soc; 1981 Mar; 29(3):205-14. PubMed ID: 7218232
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural killer activity in the peritoneal exudates of mice infected with Listeria monocytogenes: characterization of the natural killer cells by using a monoclonal rat anti-murine macrophage antibody (M1/70).
    Holmberg LA; Springer TA; Ault KA
    J Immunol; 1981 Nov; 127(5):1792-9. PubMed ID: 6795262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.